Stephen Furlong - 24 Feb 2025 Form 4/A - Amendment Insider Report for Neuronetics, Inc. (STIM)

Reporting relationship: EVP, CFO and Treasurer
Issuer ticker: STIM
Reported as of: 24 Feb 2025
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 13 Mar 2025, 17:28:03 UTC
Original report date: 26 Feb 2025
Prior SEC filing: 18 Feb 2025
Next SEC filing: 06 Mar 2025
Source filing: View source filing
Reporting owner signature: /s/ Patrick Devine, as Attorney-in-Fact

Key filing fact

Stephen Furlong filed Form 4/A - Amendment for Neuronetics, Inc. (STIM) on 13 Mar 2025.

Key facts

This page summarizes Stephen Furlong's Form 4/A - Amendment filing for Neuronetics, Inc. (STIM).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 13 Mar 2025, 17:28.

Change

Previous filing in this sequence was filed on 18 Feb 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

STIM transaction Derivative

Performance Restricted Stock Unit

Award

Transaction value: $0
Shares: +78,750
Change %
Price: $0.000000
Shares after: 78,750
Date: 24 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 78,750
Exercise price: $0.000000
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Form 4 filed on February 26, 2025 inadvertently reported that the performance restricted stock unit ("PRSU") award granted on February 24, 2025 vests in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The correct vesting dates are December 31, 2025, 2026 and 2027. The Form 4 also reported that the Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% (the "Threshold Achievement") and 110% of the target for each vesting year. However, the correct Threshold Achievement is 90%. The number of shares reflected in column 7 assumes the maximum potential vest in each vesting year.